Drug intelligence / Profile preview

12-conjugated linoleic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Conjugated linoleic acids (CLAs) are a group of positional and geometric isomers of linoleic acid found naturally in meat and dairy products from ruminant animals. The trans-10,cis-12 isomer (t10,c12-CLA), also referred to as 12-conjugated linoleic acid, is one of the two main biologically active forms present in commercial CLA supplements. This specific isomer has been studied for its anti-obesity effects—reducing body fat mass—and potential roles in modulating lipid metabolism and gene expression[5][6][8]. Mechanistically, t10,c12-CLA can decrease stearoyl-CoA desaturase activity (involved in fatty acid metabolism), reduce prostaglandin synthesis (notably PGE2), lower serum HDL cholesterol levels, and affect insulin-like growth factor-II secretion[6][8]. However, it may also increase risk factors for type 2 diabetes and heart disease by inducing hyperinsulinemia and liver steatosis[1][5]. While animal studies suggest possible benefits such as reduced inflammation or cancer risk modulation, human data remain mixed regarding efficacy for weight loss or other indications[1][4][8].

Other names
conjugated linoleic acidCLAtrans-10,cis-12 conjugated linoleic acidt10,c12-CLA
02

Targets

PPAR (PPAR family)SCD1 (Stearoyl-CoA desaturase 1)IGF2 (Insulin-like growth factor 2)

Beyond the preview

Go deeper on 12-conjugated linoleic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 12-conjugated linoleic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call